Email Us
View Reports

Global Biosurgery Market Analysis with Forecasts to 2022 | Growth Opportunities

  • ID : 1547431427  |  
  • Published : Jan-2017  |  
  • Region : Global  |  
  • Pages : 192   |  
  • Publisher : BCC Research

Report Scope:

This report analyzes the market for products used to reduce excessive hemorrhage during surgery. In a surgical procedure, these products are used as adhesion agents to seal wounds and to repair damaged or weakened tissue. This report does not consider the revenue associated with the main surgery cost; rather, it considers the revenue spent on stoppage/minimization of damage to the adjacent tissue to minimize intraoperative and postoperative complications. Due to their ease of application, these products improve the work efficiency of surgeons. Biosurgery products can be used to disinfect wounds with the help of maggots, and are used particularly for chronic infected wounds, which do not get treated by antibiotics. This report covers all of the existing applications of biosurgery products.

The global biosurgery market is segmented primarily by product type, application, source, and region. Biosurgery products are segmented by type into anti-adhesive agents, hemostatic agents, surgical sealing agents, bone-graft substitutes, and soft-tissue management. The application segments include cardiothoracic surgery, neurosurgery and spine surgery, orthopedic surgery, and general surgery. Based on source, the biosurgery market is segmented into biological and synthetic products.

An in-depth analysis of these segments is given in this report. The report also provides a detailed qualitative account of the market dynamics, technology trends, key strategies, and regulatory scenario.

The market is segmented by region into North America, Europe, Asia-Pacific, and ROW, including further division into key countries. Companies profiled in this report include Johnson & Johnson (Ethicon) Baxter International Inc., Zimmer Biomet Holdings Inc., Wright Medical Group NV, C.R. Bard Inc., Medtronic Plc, Tissuemed Ltd., CryoLife Inc., Hemostasis LLC, Cohera Medical Inc., Kuros Biosciences, B. Braun Melsungen AG, Sanofi SA, Stryker Corp., Exactech Inc., Z-Medica Corp., RTI Surgical, Smith & Nephew Plc, and HyperBranch Medical Technology Inc.

Report Includes:

- An overview of the global market for biosurgery.

- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.

- Segmentation of the market on the basis of product type, source, application, and region.

- In depth coverage of the market dynamics, technology trends, drivers, constraints, and key strategies.

- Discussion of government regulations, medical associations & international regulatory agencies.

- Analysis of patents pertaining to biosurgery.

- Profiles of companies related to the industry.

Table of Contents

Chapter 1 INTRODUCTION

STUDY OBJECTIVES

SCOPE OF REPORT

INTENDED AUDIENCE

SOURCE OF INFORMATION AND METHODOLOGY

ANALYST'S CREDENTIALS

RELATED BCC RESEARCH REPORTS

BCC RESEARCH WEBSITE

DISCLAIMER

Chapter 2 EXECUTIVE SUMMARY

Chapter 3 MARKET OVERVIEW

MARKET EVOLUTION AND INNOVATION

MERITS OF BIOSURGERY PROCEDURES

BONE-GRAFT SUBSTITUTE THERAPY

BIOLOGICAL HEMOSTATS THERAPY

BIOLOGICAL SEALANTS AND ANTI-ADHESIVE THERAPY

BIOMESH THERAPY

MAGGOT THERAPY

GOVERNMENT REGULATIONS, MEDICAL ASSOCIATIONS, AND INTERNATIONAL REGULATORY AGENCIES

RULES AND REGULATIONS SCENARIO IN THE U.S.

RULES AND REGULATIONS SCENARIO IN THE EUROPEAN UNION

RULES AND REGULATIONS SCENARIO IN CHINA

RULES AND REGULATIONS SCENARIO IN JAPAN

DEMOGRAPHICS, INCIDENCE AND PREVALENCE RATES, AND OTHER FACTORS INFLUENCING BIOSURGERY MARKET GROWTH

AGING POPULATION

INCREASING PREVALENCE OF CHRONIC DISORDERS GLOBALLY

INCREASING HEALTHCARE EXPENDITURE

CLINICAL GUIDELINES AND REIMBURSEMENT SCENARIO

U.S. HEALTHCARE STRUCTURAL CHARACTERISTICS

TECHNOLOGY TRENDS

3-D TISSUE ASSEMBLY

BIO-THYROID

PATENTS IN BIOMATERIALS

BIOSURGERY PIPELINE

NOVEL TECHNOLOGIES FOR THE FUTURE OF BIOSURGERY

3-D BIO-PRINTING

BIO-PRINTING TISSUES AND ORGANS

MEDICAL ADVANTAGES OF 3-D PRINTING IN BIOSURGERY

BIO-PRINTERS

KEY STRATEGIES

MARKET DYNAMICS

DRIVERS

RESTRAINTS

OPPORTUNITIES

Pre-Market Approval (PMA)

PMA Supplements

510(k) Notification

Traditional 510(k)

The Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (H.R. 1130, S. 598)

Medicare

Other Issues

Expected Advantages of a Bio-Thyroid

Direct Organ Manufacturing

Customization and Personalization

Bio-Printing Tissues and Organs

Customized Implants and Prostheses

Increase in the Incidence of Chronic Diseases

Increasing Geriatric Population

Increase in the Obese and Overweight Population

Advantages of Biosurgery over Traditional Surgical Methods

High Costs

Lack of Awareness and Societal Disapproval

Popularity of Minimally Invasive Surgeries

Improvement in Healthcare Infrastructure

Presence of Multifunctional Products

Chapter 4 BIOSURGERY MARKET BY PRODUCT TYPE

ANTI-ADHESIVE AGENTS

ANTI-ADHESIVE AGENTS BY APPLICATION

Pharmacological Agents

Barrier Agents

Hydro-Floatation Agents

Solid-Barrier Anti-Adhesive Agents

HEMOSTATIC AGENTS

TYPES OF HEMOSTATIC AGENTS

Mechanical Hemostatic Agents

Thermal Based-Energy Hemostatic Agents

Chemical Hemostatic Agents

Topical Hemostatic Agents

Passive Hemostatic Agents

Active Hemostatic Agents

Flowable Products

SURGICAL SEALING AGENTS

SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET

NATURAL SURGICAL SEALING AGENTS

Fibrin Sealants or Glues

Gelatin-Based Sealants

Human Fibrinogen and Thrombin Fleece

Oxidized Regenerated Methylcellulose

Albumin-Based Sealants

Glutaraldehyde-Based Adhesive

SYNTHETIC SURGICAL SEALING AGENTS

Polyethylene Glycol (PEG) Sealant

Cyanoacrylates

BONE-GRAFT SUBSTITUTES

TYPES OF BONE-GRAFT SUBSTITUTES

CELL-BASED MATRICES

Trinity Multipotential Cellular Bone Matrix

BONE MORPHOGENETIC PROTEINS

BMP-2

BMP-7

DEMINERALIZED BONE MATRIX

SYNTHETIC GRAFT EXTENDER

SOFT-TISSUE MANAGEMENT/MESH/PATCH

TYPES OF SOFT TISSUE-MANAGEMENT MESH/PATCH

Natural Mesh/Patch

Synthetic Mesh/Patch

Chapter 5 BIOSURGERY MARKET BY APPLICATION

CARDIOTHORACIC SURGERY

CARDIOVASCULAR DISEASE RISK FACTORS

COMMON SYMPTOMS OF CARDIOVASCULAR DISEASES

SYMPTOMS OF RHEUMATIC HEART DISEASE

NEUROSURGERY AND SPINE SURGERY

ORTHOPEDIC SURGERY

REVISION HIP ARTHROPLASTY

PEDIATRICS

TRAUMA SURGERY

SPORTS MEDICINE

GENERAL SURGERY

INCIDENCE RATES OF SURGICAL PROCEDURES AND ANALYSIS

Chapter 6 BIOSURGERY MARKET BY SOURCE

NATURAL/BIOLOGICAL PRODUCTS

FIBRIN-BASED PRODUCTS

ALBUMIN-BASED PRODUCTS

THROMBIN-BASED PRODUCTS

COLLAGEN-BASED PRODUCTS

GELATIN-BASED PRODUCTS

SYNTHETIC PRODUCTS

Chapter 7 COMPETITIVE LANDSCAPE

PRODUCT DEVELOPMENT

AGREEMENT

ACQUISITION

EXPANSION

Chapter 8 BIOSURGERY MARKET BY REGION

NORTH AMERICA

U.S.

CANADA

MEXICO

EUROPE

EUROPEAN UNION INVESTMENT SCENARIO

EU HEALTH PROGRAM 2014-2020

INNOVATIVE MEDICINES INITIATIVE PROGRAM

U.K.

GERMANY

FRANCE

REST OF EUROPE

ASIA-PACIFIC

CHINA

INDIA

JAPAN

AUSTRALIA

REST OF WORLD

LATIN AMERICA

Chapter 9 PATENT ANALYSIS

U.S. PATENT ANALYSIS

BY PRODUCT TYPE

BY MARKET PARTICIPANTS

EUROPE PATENT ANALYSIS

BY PRODUCT TYPE

BY MARKET PARTICIPANTS

JAPAN PATENT ANALYSIS

BY PRODUCT TYPE

BY MARKET PARTICIPANTS

CHINA PATENT ANALYSIS

BY PRODUCT TYPE

BY MARKET PARTICIPANTS

KOREA PATENT ANALYSIS

BY PRODUCT TYPE

BY MARKET PARTICIPANTS

Chapter 10 COMPANY PROFILES

B. BRAUN MELSUNGEN AG

BAXTER INTERNATIONAL INC.

CERAPEDICS INC.

COHERA MEDICAL INC.

C.R. BARD INC.

CRYOLIFE INC.

EXACTECH INC.

HEMOSTASIS LLC

HYPERBRANCH MEDICAL TECHNOLOGY INC.

JOHNSON & JOHNSON

KUROS BIOSCIENCES AG

MEDTRONIC PLC

RTI SURGICAL

SANOFI SA

SMITH & NEPHEW PLC

STRYKER CORP.

TISSUEMED LTD.

WRIGHT MEDICAL GROUP NV

Z-MEDICA CORP.

ZIMMER BIOMET HOLDINGS INC.

Chapter 11 APPENDIX

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

BIOSURGERY PRODUCT PORTFOLIO

POLYETHYLENE GLYCOL POLYMER-BASED PRODUCTS

CYANOACRYLATE-BASED PRODUCTS

BIODEGRADABLE MATERIALS

NONBIODEGRADABLE MATERIAL

REST OF ASIA

List of Tables

Summary Table : GLOBAL BIOSURGERY MARKET, BY REGION, THROUGH 2021

Table 1 : MEDICAL DEVICE CLASSIFICATION

Table 2 : TYPES OF PMA SUPPLEMENTS

Table 3 : MEDICAL DEVICES BY CLASS

Table 4 : RULES AND REGULATIONS SCENARIO IN JAPAN

Table 5 : MIMEDX: PATENT PORTFOLIO

Table 6 : GLOBAL BIOSURGERY MARKET BY PRODUCT, THROUGH 2021

Table 7 : GLOBAL MARKET FOR ANTI-ADHESIVE AGENTS BY REGION, THROUGH 2021

Table 8 : GLOBAL MARKET FOR HEMOSTATIC AGENTS BY REGION, THROUGH 2021

Table 9 : GLOBAL MARKET FOR SURGICAL SEALING AGENTS BY TYPE, THROUGH 2021

Table 10 : GLOBAL MARKET FOR SURGICAL SEALING AGENTS BY REGION, THROUGH 2021

Table 11 : KEY SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET

Table 12 : GLOBAL MARKET FOR NATURAL SURGICAL SEALING AGENTS BY REGION, THROUGH 2021

Table 13 : GLOBAL MARKET FOR SYNTHETIC SURGICAL SEALING AGENTS BY REGION, THROUGH 2021

Table 14 : GLOBAL MARKET FOR BONE-GRAFT SUBSTITUTES BY REGION, THROUGH 2021

Table 15 : DIFFERENT TYPES OF BONE-GRAFT SUBSTITUTES

Table 16 : KEY OSTEOBIOLOGIC PRODUCTS AVAILABLE IN THE MARKET

Table 17 : GLOBAL MARKET FOR BONE-GRAFT SUBSTITUTES BY TYPE, THROUGH 2021

Table 18 : GLOBAL MARKET FOR CELL-BASED MATRICES BY REGION, THROUGH 2021

Table 19 : GLOBAL MARKET FOR BONE MORPHOGENETIC PROTEINS BY REGION, THROUGH 2021

Table 20 : GLOBAL MARKET FOR DEMINERALIZED BONE MATRIX BY REGION, THROUGH 2021

Table 21 : COMMON MATERIALS USED TO MANUFACTURE SYNTHETICS

Table 22 : GLOBAL MARKET FOR SYNTHETIC GRAFT EXTENDERS BY REGION, THROUGH 2021

Table 23 : GLOBAL MARKET FOR SOFT-TISSUE PATCH/MESH BY TYPE, THROUGH 2021

Table 24 : GLOBAL MARKET FOR SOFT-TISSUE PATCH/MESH BY REGION, THROUGH 2021

Table 25 : KEY SOFT TISSUE-MANAGEMENT PRODUCTS AVAILABLE IN THE MARKET

Table 26 : KEY SURGICAL MESHES AVAILABLE IN THE MARKET

Table 27 : GLOBAL MARKET FOR NATURAL MESH/PATCH BY REGION, THROUGH 2021

Table 28 : TYPES OF NATURAL MESHES

Table 29 : GLOBAL MARKET FOR SYNTHETIC MESH/PATCH BY REGION, THROUGH 2021

Table 30 : TYPES OF SYNTHETIC MESHES

Table 31 : GLOBAL MARKET FOR BIOSURGERY BY APPLICATION, THROUGH 2021

Table 32 : GLOBAL BIOSURGERY MARKET FOR CARDIO AND THORACIC SURGERY APPLICATION BY REGION, THROUGH 2021

Table 33 : TYPES OF CARDIOVASCULAR DISEASES

Table 34 : GLOBAL BIOSURGERY MARKET FOR NEURO AND SPINE SURGERY APPLICATION BY REGION, THROUGH 2021

Table 35 : GLOBAL BIOSURGERY MARKET FOR ORTHOPEDIC SURGERY APPLICATION BY REGION, THROUGH 2021

Table 36 : STAGES OF GRAFT HEALING AND THEIR CHARACTERISTICS

Table 37 : GLOBAL BIOSURGERY MARKET FOR GENERAL SURGERY APPLICATION BY REGION, THROUGH 2021

Table 38 : GLOBAL MARKET FOR BIOSURGERY PRODUCTS BY SOURCE TYPE, THROUGH 2021

Table 39 : GLOBAL BIOSURGERY MARKET FOR NATURAL PRODUCT SOURCES BY REGION, THROUGH 2021

Table 40 : GLOBAL BIOSURGERY MARKET FOR SYNTHETIC PRODUCT SOURCES BY REGION, THROUGH 2021

Table 41 : KEY COMPETITIVE STRATEGIES, 2014-2016

Table 42 : PRODUCT DEVELOPMENT STRATEGY BY COMPANY, 2014-2016

Table 43 : LIST OF KEY PRODUCT DEVELOPMENTS ANNOUNCED, 2014-2016

Table 44 : AGREEMENT STRATEGY BY COMPANY, 2014-2016

Table 45 : LIST OF KEY AGREEMENTS ANNOUNCED, 2014-2016

Table 46 : ACQUISITIONS OR MERGERS BY COMPANY, 2014-2016

Table 47 : LIST OF KEY ACQUISITIONS ANNOUNCED, 2014-2016

Table 48 : EXPANSIONS BY COMPANY, 2014-2016

Table 49 : LIST OF KEY EXPANSIONS, 2014-2016

Table 50 : GLOBAL BIOSURGERY MARKET BY REGION, THROUGH 2021

Table 51 : NORTH AMERICAN BIOSURGERY MARKET BY PRODUCT, THROUGH 2021

Table 52 : NORTH AMERICAN BIOSURGERY MARKET BY COUNTRY, THROUGH 2021

Table 53 : TOP 10 CANADIAN MEDICAL DEVICE EXPORTS, 2012

Table 54 : EUROPEAN BIOSURGERY MARKET BY PRODUCT, THROUGH 2021

Table 55 : EUROPEAN BIOSURGERY MARKET BY COUNTRY, THROUGH 2021

Table 56 : ASIA-PACIFIC BIOSURGERY MARKET BY PRODUCT, THROUGH 2021

Table 57 : ASIA-PACIFIC BIOSURGERY MARKET BY COUNTRY, THROUGH 2021

Table 58 : REST OF WORLD BIOSURGERY MARKET BY PRODUCT, THROUGH 2021

Table 59 : REST OF WORLD BIOSURGERY MARKET BY COUNTRY, THROUGH 2021

Table 60 : B. BRAUN: RECENT DEVELOPMENTS, 2014-2016

Table 61 : B. BRAUN: FINANCIALS, 2013-2015

Table 62 : BAXTER: RECENT DEVELOPMENTS, 2014-2016

Table 63 : BAXTER: FINANCIALS, 2013-2015

Table 64 : CERAPEDICS INC.: RECENT DEVELOPMENTS, 2014-2016

Table 65 : COHERA: RECENT DEVELOPMENTS, 2014-2016

Table 66 : C.R. BARD: RECENT DEVELOPMENTS, 2014-2016

Table 67 : C.R. BARD: FINANCIALS, 2013-2015

Table 68 : CRYOLIFE: RECENT DEVELOPMENTS, 2014-2016

Table 69 : CRYOLIFE: FINANCIALS, 2013-2015

Table 70 : EXATECH INC.: RECENT DEVELOPMENTS, 2014-2016

Table 71 : EXATECH INC. FINANCIALS, 2013-2015

Table 72 : HYPERBRANCH MEDICAL TECHNOLOGY: RECENT DEVELOPMENTS, 2014-2016

Table 73 : JOHNSON & JOHNSON: RECENT DEVELOPMENTS, 2014-2016

Table 74 : JOHNSON & JOHNSON: FINANCIALS, 2013-2015

Table 75 : KUROS BIOSCIENCES: RECENT DEVELOPMENTS, 2014-2016

Table 76 : KUROS BIOSCIENCES: FINANCIALS, 2013-2015

Table 77 : MEDTRONIC: RECENT DEVELOPMENTS, 2014-2016

Table 78 : MEDTRONIC: FINANCIALS, 2014-2016

Table 79 : RTI SURGICAL: RECENT DEVELOPMENTS, 2014-2016

Table 80 : RTI SURGICAL: FINANCIALS, 2013-2015

Table 81 : SANOFI SA: RECENT DEVELOPMENTS, 2014-2016

Table 82 : SANOFI SA: FINANCIALS, 2013-2015

Table 83 : SMITH & NEPHEW: RECENT DEVELOPMENTS, 2014-2016

Table 84 : SMITH & NEPHEW: FINANCIALS, 2013-2015

Table 85 : STRYKER CORP.: RECENT DEVELOPMENTS, 2011-2016

Table 86 : STRYKER CORP.: FINANCIALS, 2013-2015

Table 87 : TISSUEMED: RECENT DEVELOPMENTS, 2014-2016

Table 88 : TISSUEMED: FINANCIALS, 2013-2015

Table 89 : WRIGHT: RECENT DEVELOPMENTS, 2014-2016

Table 90 : WRIGHT: FINANCIALS, 2013-2015

Table 91 : Z-MEDICA: RECENT DEVELOPMENTS, 2014-2016

Table 92 : ZIMMER BIOMET HOLDINGS INC.: RECENT DEVELOPMENTS, 2014-2016

Table 93 : ZIMMER BIOMET HOLDINGS INC.: FINANCIALS, 2013-2015

Table 94 : LIST OF PATENTS: U.S.

Table 95 : LIST OF PATENTS: CHINA

Table 96 : LIST OF PATENTS: JAPAN

Table 97 : LIST OF PATENTS: EUROPE

Table 98 : LIST OF PATENTS: KOREA

List of Figures

Summary Figure : GLOBAL BIOSURGERY MARKET, BY REGION, 2015-2021

Figure 1 : DIFFERENT TYPES OF BIOSURGERY THERAPIES

Figure 2 : TIMELINE OF FIBRIN SEALANTS

Figure 3 : ESTIMATED PERCENT OF DEATHS CAUSED BY CHRONIC DISORDERS, 2020

Figure 4 : NUMBER OF DEATHS CAUSED BY SEVERE CHRONIC DISORDER OR TRAUMA, 2012

Figure 5 : TOP COUNTRIES FOR HEALTH EXPENDITURES PER CAPITA

Figure 6 : PIPELINE OF BIOSURGICAL PRODUCTS

Figure 7 : KEY STRATEGIES IN BIOSURGERY MARKET

Figure 8 : GLOBAL LIFE EXPECTANCY OF GERIATRIC POPULATION, 2010-2050

Figure 9 : DIFFERENT TYPES OF NATURAL BIOSURGICAL SEALANTS

Figure 10 : STEPS INVOLVED IN DOWNSTREAM PROCESSING OF DEMINERALIZED BONE MATRIX (DBM)

Figure 11 : BONE GRAFTS: PROCESS FLOWCHART

Figure 12 : KEY COMPETITIVE STRATEGIES, 2014-2016

Figure 13 : PRODUCT DEVELOPMENT STRATEGY BY COMPANY, 2014-2016

Figure 14 : AGREEMENT STRATEGY BY COMPANY, 2014-2016

Figure 15 : ACQUISITION STRATEGY BY COMPANY, 2014-2016

Figure 16 : EXPANSION STRATEGY BY COMPANY, 2014-2016

Figure 17 : GLOBAL MARKET FOR BIOSURGERY BY REGION, 2015

Figure 18 : TOP COUNTRIES FOR AESTHETIC SURGICAL PROCEDURES, 2014

Figure 19 : PATENTS GRANTED BY DIFFERENT ORGANIZATIONS IN BIOSURGERY RESEARCH, 2015

Figure 20 : TOP COMPANIES RECEIVING PATENTS FOR BIOMATERIALS IN 2015

Figure 21 : NORTH AMERICAN SHARE OF BIOSURGERY MARKET BY COUNTRY, 2015

Figure 22 : NORTH AMERICA R&D INVESTMENT, 2014

Figure 23 : DIABETES PREVALENCE AMONG DIFFERENT AMERICAN ETHNICITIES

Figure 24 : CANADA MEDICAL DEVICE MARKET, 2012

Figure 25 : EUROPEAN BIOSURGERY MARKET BY COUNTRY, 2015

Figure 26 : BREAKDOWN OF CHRONIC DISORDERS IN EUROPE, 2015

Figure 27 : ESTIMATED EUROPEAN UNION EXPENDITURE ON RESEARCH, DEVELOPMENT AND INNOVATION, 2014-2020

Figure 28 : FLOW OF FUNDS BETWEEN THE U.K. AND EUROPEAN UNION, 2007-2013

Figure 29 : DEATHS PER 100,000 FROM HEART DISEASE IN 2013

Figure 30 : ASIA-PACIFIC BIOSURGERY MARKET BY COUNTRY, 2015

Figure 31 : BREAKDOWN OF CHRONIC DISORDERS IN CHINA (2014)

Figure 32 : TOTAL NUMBER OF DEATHS IN INDIA FROM CHRONIC DISORDERS, 2015-2020

Figure 33 : PERCENTAGE OF CARDIOVASCULAR PATIENTS BY AREA IN INDIA, 2013

Figure 34 : STRATIFICATION OF GERIATRIC POPULATION STATISTICS, BY AGE IN JAPAN

Figure 35 : REST OF WORLD BIOSURGERY MARKET BY COUNTRY, 2015

Figure 36 : PATENTS REGISTERED/APPROVED WORLDWIDE, 2010-2016

Figure 37 : U.S. PATENT ANALYSIS BY PRODUCT, 2010-2016

Figure 38 : U.S. PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016

Figure 39 : EUROPE PATENT ANALYSIS BY PRODUCT, 2010-2016

Figure 40 : EUROPE PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016

Figure 41 : JAPAN PATENT ANALYSIS BY PRODUCT, 2010-2016

Figure 42 : JAPAN PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016

Figure 43 : CHINA PATENT ANALYSIS BY PRODUCT, 2010-2016

Figure 44 : CHINA PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016

Figure 45 : KOREA PATENT ANALYSIS BY PRODUCT, 2010-2016

Figure 46 : KOREA PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016

Purchase this Market Research Report

  • SINGLE USER LICENSE
    Single user license allows one specific user to access the product.
  • TEAM LICENSE
    Team License allows multiple users to access the product.
  • CORPORATE LICENSE
    Corporate License allows users across the whole organization to access the product.

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?